Search Results
Apr 16, 2026, 08:00 ET Oracle and AWS Collaborate to Expand Multicloud Networking
are registered trademarks of Oracle Corporation. NetSuite was the first cloud company—ushering in the new era of cloud computing.Contact InfoOracle PRBen [email protected]+1.510.480.5230
More news about: Oracle
Apr 16, 2026, 02:19 ET VTT-originated startup Proteins.1 launches to bring PCR-like amplification and simplicity to omics
https://news.cision.com/vtt-info/r/vtt-originated-startup-proteins-1-launches-to-bring-pcr-like-amplification-and-simplicity-to-omics,c4335346The following files are available for download:
More news about: VTT Info
Apr 15, 2026, 15:09 ET $HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--FORA, SLNO, MKC, and OMEX
OMEX) related to its merger with American Ocean Minerals Corporation.Click here for more info
More news about: Monteverde & Associates PC
Apr 15, 2026, 15:09 ET $HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--WSR, ASRT, EHAB, and SEM
terms of the proposed transaction, Select Medical shareholders are expected to receive $16.50 per share in cash.Click here for more info
More news about: Monteverde & Associates PC
Apr 15, 2026, 14:51 ET Most Organizations Invest in Marketing Without a Clear Brand Foundation, Says Info-Tech Research Group
following the framework outlined in Info-Tech's blueprint, organizations can establish a cohesive brand strategy that guides decision-making, aligns internal teams, and delivers consistent value to customers over time.For exclusive and timely commentary from Info-Tech's experts, including Nathalie Vezina,
More news about: Info-Tech Research Group
Apr 15, 2026, 08:04 ET ROB GRONKOWSKI'S "GRONK BEACH - PRESENTED BY DOORDASH" RETURNS TO WRESTLEMANIA® WEEK IN LAS VEGAS TAKING OVER MARQUEE ON SUNDAY, APRIL 19, 2026
30 alumni, have graced the Pollstar Next Gen and Variety New Leaders lists in 2020 and 2021, respectively, and were showcased as INC 5000. For more info, visit
More news about: Medium Rare
Apr 14, 2026, 14:02 ET Certificate Lifecycle Management Fails Without Automation as Certificate Sprawl and Shortened Lifespans Increase Risk, Finds Info-Tech Research Group
well-informed decisions. For nearly 30 years, Info-Tech has partnered closely with teams to provide everything they need, from actionable tools to expert guidance, ensuring they deliver measurable results for their organizations.To learn more about Info-Tech's HR research and advisory services, visit
More news about: Info-Tech Research Group
Apr 14, 2026, 12:18 ET Tetragon Financial Group Limited Announcement of Final Results of Tender Offer to Purchase Tetragon Non-Voting Shares
www.tetragoninv.com/shareholders/additional-info/.Tetragon Investor Relations:Yuko [email protected]
More news about: Tetragon Financial Group Limited
Apr 14, 2026, 08:30 ET Briya Hits 120M Patient Journeys Milestone to Accelerate AI-Driven Medical Research
information or to request a demo, please visit: Briya AIRE Info RequestAbout BriyaBriya is a healthcare technology company dedicated to supporting vital medical and biopharma research and
More news about: Briya
Apr 14, 2026, 08:22 ET Solv Wellness Expands Perimenopause and Menopause Support with New Essentials Line
hcp.solvwellness.com. Contact Info:Candice MailmanMarketing [email protected]+1
More news about: Solv Wellness®
Apr 13, 2026, 15:00 ET TBL Team Boxing League Finalizes Landmark Partnership with Manny Pacquiao, Who Enters Franchise Ownership
TBL Team Boxing League, visit www.teamboxingleague.com for schedules, tickets, and team info. You can also download the TBL app from the App Store for additional information.About TBL Team Boxing LeagueThrough its innovative
More news about: Team Boxing League
Apr 13, 2026, 13:05 ET AI Exposes Information Management Gaps That Limit Business Value, Says Info-Tech Research Group
organization's ability to secure investment and sustain momentum.Info-Tech's Practical Framework for AI-Powered Information ManagementTo help IT leaders modernize their IM approach, Info-Tech's
More news about: Info-Tech Research Group
Apr 13, 2026, 10:33 ET Badanie DOORwaY90 firmy Sirtex Medical wskazuje na 100% miejscową kontrolę nowotworu przy pomocy SIR-Spheres®, ustanawiając nowy punkt odniesienia w zakresie terapii Y-90 w przypadku nieoperacyjnego raka wątrobowokomórkowego
SIR-Spheres® do swojej praktyki, prosimy o kontakt z firmą Sirtex pod adresem [email protected].SIR-Spheres Mikrosfery żywiczne SIR-Spheres® Y-90 są wskazane do miejscowej kontroli nowotworu w przypadku
More news about: Sirtex Medical Inc.
Apr 13, 2026, 09:00 ET Sirtex MedicalのDOORwaY90試験でSIR-Spheres®による100%の局所腫瘍制御が実証され、肝細胞癌に対するY-90療法の新たなベンチマークが確立される
Y-90樹脂マイクロスフェアは、米国において、転移性大腸癌（mCRC）および切除不能な肝細胞癌の治療薬としてFDAに承認された唯一の放射性塞栓療法となります。SIR-Spheres の詳細および個別化線量測定を臨床に取り入れるためのガイダンスについては、Sirtex [email protected]までお問い合わせください。SIR-Spheres についてSIR-Spheres®Y-90 樹脂マイクロスフェアは、大血管浸潤がない切除不能な肝細胞癌（HCC）の局所腫瘍制御を目的とした治療法として適応が承認されています。対象となるのは、Child-Pugh
More news about: Sirtex Medical Inc.
Apr 13, 2026, 09:00 ET Sirtex Medical's DOORwaY90 Study Demonstrates 100% Local Tumor Control with SIR-Spheres®, Setting a New Benchmark in Y-90 for HCC
personalized dosimetry into clinical practice, please contact Sirtex at [email protected].About SIR-SpheresSIR-Spheres® Y-90 resin microspheres are indicated for the local tumor control of unresectable
More news about: Sirtex Medical Inc.
Apr 13, 2026, 09:00 ET Sirtex Medical's DOORwaY90 Study Demonstrates 100% Local Tumor Control with SIR-Spheres®, Setting a New Benchmark in Y-90 for HCC
personalized dosimetry into clinical practice, please contact Sirtex at [email protected].About SIR-SpheresSIR-Spheres® Y-90 resin microspheres are indicated for the local tumor control of unresectable
More news about: Sirtex Medical Inc.
Apr 13, 2026, 09:00 ET Исследование DOORwaY90 компании Sirtex Medical демонстрирует 100% локальный контроль опухоли с помощью SIR-Spheres®, устанавливая новый ориентир в Y-90 для ГЦК
персонализированной дозиметрии в клиническую практику свяжитесь с Sirtex по адресу [email protected].О SIR-SpheresСмоляные микросферыSIR-Spheres ® Y-90 показаны для локального контроля опухоли неоперабельной
More news about: Sirtex Medical Inc.
Apr 13, 2026, 09:00 ET Štúdia DOORwaY90 spoločnosti Sirtex Medical preukazuje 100 % lokálnu kontrolu nádoru pomocou SIR-Spheres®, čím stanovuje nový štandard pri liečbe Y-90 hepatocelulárneho karcinómu
dozimetrie do klinickej praxe získate od spoločnosti Sirtex na adrese [email protected].O SIR-SpheresŽivicové mikroguličky SIR-Spheres® Y-90 sú indikované na lokálnu kontrolu nádoru neresekovateľného
More news about: Sirtex Medical Inc.
Apr 13, 2026, 09:00 ET Studie DOORwaY90 společnosti Sirtex Medical prokázala stoprocentní lokální kontrolu nádoru pomocí SIR-Spheres® a stanovila tak nový standard v léčbě HCC pomocí Y-90
personalizované dozimetrie do klinické praxe kontaktujte společnost Sirtex na adrese [email protected].O SIR-SpheresMikrokuličky z pryskyřice SIR-Spheres® Y-90 jsou indikovány k lokální kontrole nádoru u neoperovatelného
More news about: Sirtex Medical Inc.
Apr 13, 2026, 09:00 ET Studi DOORwaY90 dari Sirtex Medical Mendemonstrasikan Kontrol Tumor Lokal 100% dengan SIR-Spheres®, Menetapkan Tolok Ukur Baru di Y-90 untuk HCC
yang dipersonalisasi ke dalam praktik klinis, silakan hubungi Sirtex di [email protected].Tentang SIR-SpheresSIR-Spheres® Mikrosfer resin Y-90 diindikasikan untuk pengendalian tumor lokal karsinoma
More news about: Sirtex Medical Inc.
Apr 13, 2026, 09:00 ET O estudo DOORwaY90 da Sirtex Medical demonstra 100% de controle tumoral local com SIR-Spheres®, estabelecendo um novo padrão de referência para o Y-90 no tratamento do CHC
sua atividade profissional, entre em contato com a Sirtex pelo e-mail [email protected].Sobre as SIR-SpheresAs microesferas de resina SIR-Spheres® Y-90 são indicadas para o controle tumoral local
More news about: Sirtex Medical Inc.
Apr 13, 2026, 09:00 ET El estudio DOORwaY90 de Sirtex Medical demuestra un control tumoral local del 100 % con SIR-Spheres®
personalizada a la práctica clínica, póngase en contacto con Sirtex en [email protected].Acerca de SIR-SpheresLas microesferas de resina SIR-Spheres® Y-90 están indicadas para el control tumoral local del
More news about: Sirtex Medical Inc.
Apr 13, 2026, 09:00 ET El ensayo clínico DOORwaY90 de Sirtex Medical demuestra controlar en un 100 % los tumores locales con las microesferas SIR-Spheres®, lo que establece un nuevo referente en el tratamiento con Y-90 para el carcinoma hepatocelular
dosimetría personalizada a la práctica clínica, comuníquese con Sirtex al [email protected].Acerca de SIR-SpheresLas microesferas de resina SIR-Spheres® Y-90 están indicadas para el control tumoral
More news about: Sirtex Medical Inc.
Apr 13, 2026, 09:00 ET L'étude DOORwaY90 de Sirtex Medical démontre un contrôle local de la tumeur de 100 % avec SIR-Spheres®, établissant ainsi une nouvelle référence pour l'Y-90 dans le traitement du CHC
la pratique clinique, veuillez contacter Sirtex à l'adresse suivante : [email protected].À propos de SIR-SpheresLes microsphères de résine Y-90 SIR-Spheres® sont indiquées pour le contrôle local
More news about: Sirtex Medical Inc.
Apr 13, 2026, 09:00 ET Nghiên Cứu DOORwaY90 của Sirtex Medical Chứng Minh Khả Năng Kiểm Soát Khối U Tại Chỗ đạt 100% với SIR-Spheres®, Thiết Lập Chuẩn Mực Mới Trong Điều Trị HCC bằng Y-90
thể hóa vào thực hành lâm sàng, vui lòng liên hệ với Sirtex qua email: [email protected].Giới thiệu về SIR-SpheresHạt vi cầu nhựa SIR-Spheres® Y-90 được chỉ định để kiểm soát khối u tại chỗ đối
More news about: Sirtex Medical Inc.